Back to Search Start Over

An Update on the Genetic Drivers of Corticotroph Tumorigenesis.

Authors :
Hernández-Ramírez LC
Perez-Rivas LG
Theodoropoulou M
Korbonits M
Source :
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association [Exp Clin Endocrinol Diabetes] 2024 Dec; Vol. 132 (12), pp. 678-696. Date of Electronic Publication: 2024 Jun 03.
Publication Year :
2024

Abstract

The genetic landscape of corticotroph tumours of the pituitary gland has dramatically changed over the last 10 years. Somatic changes in the USP8 gene account for the most common genetic defect in corticotrophinomas, especially in females, while variants in TP53 or ATRX are associated with a subset of aggressive tumours. Germline defects have also been identified in patients with Cushing's disease: some are well-established ( MEN1, CDKN1B, DICER1 ), while others are rare and could represent coincidences. In this review, we summarise the current knowledge on the genetic drivers of corticotroph tumorigenesis, their molecular consequences, and their impact on the clinical presentation and prognosis.<br />Competing Interests: The authors declare that they have no conflict of interest.<br /> (Thieme. All rights reserved.)

Details

Language :
English
ISSN :
1439-3646
Volume :
132
Issue :
12
Database :
MEDLINE
Journal :
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Publication Type :
Academic Journal
Accession number :
38830604
Full Text :
https://doi.org/10.1055/a-2337-2265